Showing results (1191-1200 of 1,900) with videos related to

Sort By:
Pageof 190
Cancer|February 1, 1984
Adriamycin and cyclophosphamide versus hydroxyurea in advanced prostatic cancer. A randomized Southwest Oncology Group studyR L Stephens, C Vaughn, M Lane, et al.
Ophthalmic Plastic and Reconstructive Surgery|November 27, 2008
Postoperative adjuvant external-beam radiation therapy for cancers of the eyelid and conjunctivaAdam Hsu, Steven J Frank, Matthew T Ballo, et al.
Materials (Basel, Switzerland)|August 10, 2017
Cathodic Polarization Coats Titanium Based Implant Materials with Enamel Matrix Derivate (EMD)Matthias J Frank, Martin S Walter, Marina Rubert, et al.
Reviews in the Neurosciences|March 17, 2016
Interrelations between cognitive dysfunction and motor symptoms of Parkinson's disease: behavioral and neural studiesAhmed A Moustafa, Srinivasa Chakravarthy, Joseph R Phillips, et al.
Physics in Medicine and Biology|April 30, 2014
MRI characterization of cobalt dichloride-N-acetyl cysteine (C4) contrast agent marker for prostate brachytherapyTze Yee Lim, R Jason Stafford, Rajat J Kudchadker, et al.
Cancer|July 14, 2011
Outcomes after prostate brachytherapy are even better than predictedSteven J Frank, Lawrence B Levy, Marco van Vulpen, et al.
Journal of Clinical Pharmacology|March 1, 1991
Mexiletine versus quinidine as first-line antiarrhythmia therapy: results from consecutive trialsM J Frank, L O Watkins, L M Prisant, et al.
Medical Physics|July 3, 2016
Effect of pulse sequence parameter selection on signal strength in positive-contrast MRI markers for MRI-based prostate postimplant assessmentTze Yee Lim, Rajat J Kudchadker, Jihong Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2010
Respiratory organ motion and dosimetric impact on breast and nodal irradiationX Sharon Qi, Julia White, Rachel Rabinovitch, et al.
Biopharmaceutics & Drug Disposition|April 1, 1990
Multiple-dose propranolol administration does not influence the single dose pharmacokinetics of quinapril and its active metabolite (quinaprilat)A M Horvath, D Pilon, G Caillé, et al.
Pageof 190